tiprankstipranks
TipRanksTop Financial ExpertsInsidersMatthew L. Kaplan

Matthew L. Kaplan Insider Profile

4 Followers
Matthew L. Kaplan, Director at Nuvectis Pharma, holds 159.76K shares in Nuvectis Pharma (Ticker: NVCT).
See the Hottest Stocks Based on Insider Trading >
tipranks
Matthew L. Kaplan

Matthew L. Kaplan
Nuvectis Pharma (NVCT)
Director

Ranked #25,212 out of 108,198 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+106.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$3M
100.00%
A breakdown of Matthew L. Kaplan's holdings
See the Top Stocks by Insiders

Insider Roles

Nuvectis Pharma
(NVCT)
Director
Roles that Matthew L. Kaplan holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Nuvectis Pharma
(NVCT)
Rating:Informative Buy
Date:Nov 06, 2025 - Today
Return:+223.60%
The most profitable trade made by Matthew L. Kaplan
See the Latest Stocks Traded by Insiders

Matthew L. Kaplan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NVCT
Nuvectis Pharma
Jun 12, 2026
Director
Uninformative Buy
―
$3.06M
Success Rate for
NVCT
1 out of 2 profitable transactions on
NVCT
50%
Average Return for
NVCT
Average return per transaction on
NVCT
+106.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 16, 2022
Informative Buy
$50.63K
3,000
$16.87
-11.00%
Jun 20, 2023
Uninformative Buy
$0.00
18,000
$0.00
―
Jun 13, 2024
Uninformative Buy
$0.00
30,000
$0.00
―
Jun 12, 2025
Uninformative Buy
$0.00
30,000
$0.00
―
Nov 06, 2025
Informative Buy
$64.24K
11,000
$5.84
+223.60%
List of latest transactions for each holding click on a transaction to see Matthew L. Kaplan's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Matthew L. Kaplan insider profile FAQ

What is the percentage of profitable transactions made by Matthew L. Kaplan?
The percentage of profitable transactions made by Matthew L. Kaplan is 50%.
    What is the average return per transaction made by Matthew L. Kaplan?
    The average return per transaction made by Matthew L. Kaplan is 106.30%.
      What stocks does Matthew L. Kaplan hold?
      Matthew L. Kaplan holds: NVCT stocks.
        What was Matthew L. Kaplan’s latest transaction?
        Matthew L. Kaplan latest transaction was an Uninformative Buy of ―.
          What was Matthew L. Kaplan's most profitable transaction?
          Matthew L. Kaplan’s most profitable transaction was an Informative Buy of NVCT stock on November 6, 2025. The return on the trade was 223.60%.
            What is Matthew L. Kaplan's role in Nuvectis Pharma?
            Matthew L. Kaplan's role in Nuvectis Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.